Last updated: Oct 30, 2026, 12:00 AM

Allogene Therapeutics Inc Exchange (NASDAQ, USD)

ALLO

1.30
+0.07 (+5.69%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
5.69%
3 year return (CAGR)
-22.38%
5 year return (CAGR)
-39.33%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
449.14M
Price/Sales
96.80
Ent value
524.43M
Price/Book
1.03
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-16.08%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open1.22
Daily high1.33
Daily low1.21
Daily Volume10.3M
All-time high54.04
1y analyst estimate9.00
Beta0.48
EPS (TTM)-0.50
Dividend per share0.00
Ex-div date-
Next earnings date4 Mar 2026

Ready to capitalize on Allogene Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
ALLOS&P500
Current price drop from All-time high-97.59%-0.87%
Highest price drop-98.24%-56.47%
Date of highest drop14 May 20259 Mar 2009
Avg drop from high-67.36%-10.65%
Avg time to new high156 days12 days
Max time to new high1617 days1805 days